1-5 of 5
Silvana Pasini
Close
Sort by
Journal Articles

Autologous Peripheral Blood Stem-Cell (PBSC) Collection Is Not Impaired by Bortezomib-Thalidomide-Dexamethasone (VTD) Induction Therapy in Newly Diagnosed Multiple Myeloma (MM)

Annamaria Brioli, MD, Giulia Perrone, MD, Silvestro Volpe, MD, Silvana Pasini, MD, Anna Mele, MD, Fausto Rossini, MD, Anna Marina Liberati, MD, Luca De Rosa, MD, Giuseppe Avvisati, MD, Sergio Amadori, MD, Alessandro Gozzetti, MD, Antonio Capaldi, MD, Giuseppe Mele, MD, Giuliana Farina, MD, Elena Zamagni, MD, Ernesto Vigna, MD, Silvana Capalbo, MD, Michele Magni, MD, Giuseppe Rodolfo Nunziata, MD, Monica Crugnola, MD, Vittorio Fregoni, MD, Giuliana Leopardi, MD, Immacolata Attolico, MD, Alessandro Moscetti, MD, Luigi Podda, MD, Patrizia Pregno, MD, Michele Baccarani, MD, Michele Cavo, MD
Journal: Blood
Blood (2011) 118 (21): 317.
https://doi.org/10.1182/blood.V118.21.317.317
Published: 2011
Journal Articles

Long Term Efficacy of Percutaneous Vertebroplasty in Multiple Myeloma (MM) Patients: Experience of the “Gruppo Ematologico Di Romagna” (GER)

Patrizia Tosi, MD, Annalia Molinari, MD, Michele Sintini, MD, Anna Merli, MD, Michela Ceccolini, MD, Manuela Imola, MD, Paolo Savini, MD, Silvana Pasini, MD, Anna M Mianulli, MD, Barbara Castagnari, MD, Pier P Fattori, MD, Giovanni Martinelli, MD, PhD, Alfonso Zaccaria
Journal: Blood
Blood (2011) 118 (21): 5123.
https://doi.org/10.1182/blood.V118.21.5123.5123
Published: 2011
Journal Articles

Bortezomib-Based Induction Treatments Improve Outcomes of Newly Diagnosed Multiple Myeloma Patients with High-Risk Cytogenetic Abnormalities

Michele Cavo, Sara Bringhen, Carolina Terragna, Paola Omedè, Giulia Marzocchi, Marina Ruggeri, Sandra Durante, Maria Teresa Petrucci, Tommasina Guglielmelli, Giulia Benevolo, Vittorio Montefusco, Franco Narni, Antonietta Falcone, Catello Califano, Anna Baraldi, Silvana Pasini, Piero Galieni, Fortunato Morabito, Mariella Grasso, Daniela Gottardi, Vincenzo Rizzo, Mario Boccadoro, Nicoletta Testoni, Antonio Palumbo
Journal: Blood
Blood (2010) 116 (21): 781.
https://doi.org/10.1182/blood.V116.21.781.781
Published: 2010
Journal Articles

Superior Rate of Complete Response with up-Front Velcade-Thalidomide-Dexamethasone Versus Thalidomide-Dexamethasone in Newly Diagnosed Multiple Myeloma Is Not Affected by Adverse Prognostic Factors, Including High-Risk Cytogenetic Abnormalities.

Michele Cavo, M.D., Nicoletta Testoni, B.S., Carolina Terragna, B.S., Giulia Marzocchi, B.S., Sandra Durante, B.S., Renato Zambello, M.D., Chiara Nozzoli, M.D., Lucia Pantani, M.D., Paola Tacchetti, M.D., Luciano Masini, M.D., Michela Ceccolini, M.D., Paola Agostini, M.D., Elena Zamagni, M.D., Valerio De Stefano, M.D., Patrizia Tosi, M.D., Daniele Derudas, M.D., Laura Dessanti, M.D., Stelvio Ballanti, M.D., Salvatore Palmieri, M.D., Andrea Nozza, M.D., Gioacchino Catania, M.D., Jacopo Peccatori, M.D., Alfonso D’Arco, M.D., Pellegrino Musto, M.D., Mariella Grasso, M.D., Maria Caterina Pallotti, M.D., Silvana Pasini, M.D., Pier Paolo Fattori, M.D., Anna Baraldi, M.D., Delia Cangini, M.D., Filippo Ballerini, M.D., Alessandro Petrucci, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2008) 112 (11): 1662.
https://doi.org/10.1182/blood.V112.11.1662.1662
Published: 2008
Journal Articles

Superiority of Double over Single Autologous Stem-Cell Transplantation for Newly Diagnosed Multiple Myeloma and Prognostic Impact of Complete Response: Final Analysis of “Bologna 96” Study.

Michele Cavo, MD, Giulia Perrone, M.D., Michela Ceccolini, M.D., Vito Michele Lauta, M.D., Massimo Offidani, M.D., Filippo Ballerini, M.D., Lucia Pantani, M.D., Annamaria Brioli, M.D., Silvana Pasini, M.D., Fausto Dore, M.D., Domenico Vertone, M.D., Paola Tacchetti, M.D., Elena Zamagni, M.D., Patrizia Tosi, M.D., Sante Tura, M.D., Michele Baccarani, M.D.
Journal: Blood
Blood (2007) 110 (11): 730.
https://doi.org/10.1182/blood.V110.11.730.730
Published: 2007